Drawing for ARIA PHARMACEUTICALS

USPTO serial 90306954

ARIA PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ORNDORFF, LINDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARIA PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nadya M. Sand

Nadya M. Sand ALSTON & BIRD LLP1201 W. Peachtree StreetAtlanta, GA 30309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Drug discovery services; pharmaceutical drug development servicesACTIVE—
045Licensing of intellectual property rights in the pharmaceutical industryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 21, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 21, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 7, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2023EX3GSOU EXTENSION 3 GRANTED—
Jan 5, 2023EXT3SOU EXTENSION 3 FILED—
Jan 5, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 26, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 25, 2022EX2GSOU EXTENSION 2 GRANTED—
Jul 20, 2022EXT2SOU EXTENSION 2 FILED—
Jul 20, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 19, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 19, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 19, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 19, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 29, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 28, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 28, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 15, 2021EXT1SOU EXTENSION 1 FILED—
Dec 15, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 25, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Apr 19, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 19, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 19, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 16, 2021DOCKASSIGNED TO EXAMINER—
Jan 8, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 7, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance